Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tipifarnib in Advanced Colorectal Cancer
NCT00005833Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Jun 2000
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tipifarnib in colorectal cancer (CRC), sponsored by SWOG Cancer Research Network. Started Jun 2000; status: completed.
02
Drugs
tipifarnib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00005833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005833.